Home    Back

Meropenem infusion    (DrugBank: Meropenem)

2 diseases
IDDisease name (Link within this page)Number of trials
60Aplastic anemia0
299Cystic fibrosis1

60. Aplastic anemia    [ 218 clinical trials,   362 drugs,   (DrugBank: 81 drugs),   39 drug target genes,   155 drug target pathways]
Searched query = "Aplastic anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 218 trial found

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01158937
(ClinicalTrials.gov)		May 20107/7/2010Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis PatientsPharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patient With Exacerbation of Pulmonary InfectionCystic Fibrosis Pulmonary ExacerbationDrug: Meropenem InfusionSt. Michael's Hospital, TorontoSunnybrook Health Sciences Centre;University of TorontoTerminated18 YearsN/ABoth2N/ACanada